SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

ImmunoCellular Therapeutics, Ltd. (IMUC)

IMUC RSS Feed
Add IMUC Price Alert      Hide Sticky   Hide Intro
Moderator: makingbiigdough, beambe, PyschoNoobStock
Search This Board: 
Last Post: 10/20/2017 3:32:08 PM - Followers: 181 - Board type: Free - Posts Today: 0

 


 

 

ImmunoCellular Therapeutics continues to make significant progress in meeting important goals and positioning the company for success. We believe that our cancer vaccine platform has the potential to be transformative in the treatment of cancer, and to create value for all our stakeholders. Our goal is to build ImmunoCellular into a leading, independent commercial-stage cancer immunotherapy company.





Our dendritic cell (DC) vaccine technology and advanced manufacturing offer several advantages over earlier-generation cellular immunotherapies:

Potency
- Matured DCs secrete IL12, which is critical for stimulating T cell killing of cancer cells.
More than 80% of the final manufactured product consists of matured DCs.

Versatility
- Unlike other cell-based vaccines, our DCs target multiple antigens, thus increasing the likelihood of effective treatment.

Efficiency
- Advanced manufacturing enables production of at least 20 doses of vaccine from a single apheresis (blood collection); thus patients do not need to undergo additional apheresis procedures.

Cost-effectiveness
- Compared to the only approved cell-based immunotherapy, our DC vaccines can be manufactured at a significantly reduced cost.

Convenience
- Ability to freeze and store vaccine for months or years eliminates the need to administer to the patient shortly after manufacture.
- Intradermal administration route reduces the time and inconvenience of intravenous infusion for both patient and physician.


Company Information:

21900 Burbank, 3rd Floor
Woodland Hills, CA 91367

Phone: 818-992-2907

http://www.imuc.com 

-
Management:
  
http://imuc.com/team/

Technologies:   http://imuc.com/technology/

Press Releases:   http://imuc.com/press/

http://finance.yahoo.com/q/h?s=IMUC+Headlines
 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0000822411&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 -

Transfer Agent:

U.S. Stock Transfer Corp.
Suite 200
Glendale, CA 91204-2991

 Investor Relations:

Gary Nash, CEOcast, Inc.

Tel: (212)732-4300
Email: IR@imuc.com




 

 PIPELINE 







http://www.imuc.com/pipeline/ict-107/ict-107-faq

http://www.imuc.com/pipeline/ict-121

http://www.imuc.com/pipeline/ict-140



 UPDATE 



ImmunoCellular has concluded a phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular's pipeline also includes: ICT-121, a dendritic cell vaccine targeting CD133; ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells; and the Stem-to-T-cell research program which engineers the patient's hematopoietic stem cells to generate antigen-specific cancer killing T-cells.

Announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM). This agreement with PharmaCell, a leading European contract manufacturing organization focuses on the production of human cell therapy products, and is designed to enable ImmunoCellular to access phase 3 supplies of ICT-107, manufactured with ImmunoCellular's commercial-ready production process. ImmunoCellular intends to initiate a Phase 3 registrational program for ICT-107 in the US and in Europe in 2015
.   


>>> What these CANCER vaccines could be worth
 

 NEW  


Investor Presentation -> http://files.shareholder.com/downloads/AMDA-1HS8HT/61684022x0x652321/5FD13B20-8F93-44CE-994E-D5515E5F30FC/IMI_Corporate_Overview.pdf 



 

 

 

 

SureTrader
Interactive Brokers Advertisement
IMUC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IMUC News: Current Report Filing (8-k) 10/11/2017 08:32:29 AM
IMUC News: ImmunoCellular Therapeutics to Present at the Lytham Partners Virtual Investor Conference on October 11, 2017 at 2:00pm ET 10/03/2017 06:00:00 AM
IMUC News: ImmunoCellular Therapeutics Announces NYSE MKT Acceptance of its Plan of Compliance 09/13/2017 04:05:00 PM
IMUC News: Current Report Filing (8-k) 08/28/2017 04:32:17 PM
IMUC News: ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future Strategy 08/23/2017 04:05:00 PM
PostSubject
#4194  Sticky Note ImmunoCellular Therapeutics to Present at the Lytham Partners PyschoNoobStock 10/03/17 10:13:14 AM
#4591   .41 and .42 size got smaller.. PyschoNoobStock 10/20/17 03:32:08 PM
#4590   Youre right on time buddy! Joecanada13 10/20/17 03:31:05 PM
#4589   Nah.. PyschoNoobStock 10/20/17 03:29:43 PM
#4588   Oops, shoulda waited? cjf913913 10/20/17 03:29:07 PM
#4587   Loading.. PyschoNoobStock 10/20/17 03:12:23 PM
#4586   Weeeeee PyschoNoobStock 10/20/17 03:11:25 PM
#4585   Back in action!! Joecanada13 10/20/17 03:09:03 PM
#4584   .40 is broken! BOOM TIME! PyschoNoobStock 10/20/17 03:05:07 PM
#4583   Levell 2 Data THIN!! PyschoNoobStock 10/20/17 03:02:14 PM
#4582   Pretty please, can we break .40! PyschoNoobStock 10/20/17 02:58:02 PM
#4581   Slowly tightening up for next leg. Hopefully someone Joecanada13 10/20/17 11:49:06 AM
#4580   More likely.. PyschoNoobStock 10/20/17 10:40:35 AM
#4579   Time to Load the boat. .37 looks like Beasy324 10/20/17 10:39:56 AM
#4578   Bios down again today!! Joecanada13 10/19/17 11:02:31 AM
#4577   Indeed.. PyschoNoobStock 10/19/17 10:53:24 AM
#4576   Agreed, it's very good this didn't break $.37 Dmwcrash 10/19/17 10:47:16 AM
#4575   Look good! Strong support.. PyschoNoobStock 10/19/17 09:47:11 AM
#4574   In addition to chart analysis, see the June Craig305 10/19/17 09:38:10 AM
#4573   Doing some scans tonight found this, chart looks ttrader707 10/18/17 10:51:44 PM
#4572   Soon pass .40! PyschoNoobStock 10/18/17 03:11:44 PM
#4571   Oops wrong stock. Meant NEOT Joecanada13 10/18/17 10:16:57 AM
#4570   I owned 100k shares @ .40 :( Joecanada13 10/18/17 10:16:19 AM
#4569   Yea wish I had bought $200 back at .35 CrazyKar123 10/18/17 12:59:10 AM
#4568   hit .40 AH, good sign for tomorrow! peonofstocks 10/17/17 07:36:34 PM
#4567   Another great day! PyschoNoobStock 10/17/17 10:25:09 AM
#4566   Nice nice! Joecanada13 10/17/17 10:02:22 AM
#4565   Thanks! PyschoNoobStock 10/16/17 08:52:08 PM
#4564   It looks like that 440k trade AH was UFO 10/16/17 08:10:26 PM
#4563   Holy (bleep) jesus.. 440K sell after hour? Dilutions? PyschoNoobStock 10/16/17 05:44:49 PM
#4562   A big fat nothing burger. Joecanada13 10/16/17 04:22:52 PM
#4561   No no beambe 10/16/17 03:55:29 PM
#4560   Yeah it was open early this year in PyschoNoobStock 10/16/17 03:41:07 PM
#4559   Cause that's what ide wanna do!!! Ahha best Joecanada13 10/16/17 03:39:09 PM
#4558   $IMUC lookin good! PyschoNoobStock 10/16/17 03:28:55 PM
#4557   Hahah.. How you know? I went snowboarding in PyschoNoobStock 10/16/17 03:09:13 PM
#4556   Hit the slopes!? Joecanada13 10/16/17 03:07:34 PM
#4555   Oh (bleep) ya.. I need it! I was PyschoNoobStock 10/16/17 03:04:17 PM
#4554   Ahha missed ya bro! Have a good trip? Joecanada13 10/16/17 03:03:04 PM
#4553   Finally at last! Im back.. I was out PyschoNoobStock 10/16/17 03:00:16 PM
#4552   Nice start today! Joecanada13 10/16/17 09:45:33 AM
#4551   Just maybe We see a break out this batmen 10/14/17 09:07:53 AM
#4550   Which it did :) Joecanada13 10/13/17 04:21:30 PM
#4549   Very bullish if it closes over ,375. Hagwë declaes 10/13/17 03:58:06 PM
#4548   Green! Joecanada13 10/13/17 03:43:36 PM
#4547   Tapped it this morning :p Joecanada13 10/13/17 11:39:05 AM
#4546   Slow march back to .40 then onwards! Joecanada13 10/12/17 12:37:23 PM
#4545   Added again today. Added some everyday this week :) TheInvincibleBull 10/12/17 11:08:04 AM
#4544   Slow covering going on Joecanada13 10/12/17 10:16:14 AM
#4543   Very light volume this morning.Watching for the selling rarefind 10/12/17 09:47:15 AM
#4542   They basically said they are in talks with Joecanada13 10/11/17 07:20:45 PM
PostSubject